Breaking: J&J looks at potential bid for Intra-Cellular — reportnews2025-01-12T22:55:47+00:00January 12th, 2025|Endpoints News|
Biogen offers to buy Sage Therapeutics for $469Mnews2025-01-10T23:58:00+00:00January 10th, 2025|Endpoints News|
City Therapeutics, Bausch + Lomb partner on preclinical RNAi eye drugnews2025-01-10T15:11:19+00:00January 10th, 2025|Endpoints News|
Four biotechs emerge with $800M and in-licensed assets on Fridaynews2025-01-10T15:04:37+00:00January 10th, 2025|Endpoints News|
Another biotech scoops up asset from China-based Keymed and nabs $180Mnews2025-01-10T12:19:00+00:00January 10th, 2025|Endpoints News|
Lilly ventures into pulmonary fibrosis with startup Mediarnews2025-01-10T12:00:05+00:00January 10th, 2025|Endpoints News|
After lackluster 2024, biopharma industry prays stalled M&A will finally move into gearnews2025-01-09T16:06:46+00:00January 9th, 2025|Endpoints News|
Versant unveils Light Horse with $62M and a partnership with Novartisnews2025-01-09T14:32:48+00:00January 9th, 2025|Endpoints News|
Leyden Labs gets $70M to test if nasal sprays can help protect against virusesnews2025-01-09T13:00:32+00:00January 9th, 2025|Endpoints News|
Lonza’s Synaffix adds Boehringer and Mitsubishi Tanabe as ADC licensing partnersnews2025-01-09T13:00:07+00:00January 9th, 2025|Endpoints News|
